NCT06598163 · RECRUITING
Five Lives MED to Improve Cognitive Function in Mild Cognitive Impairment
This trial tests whether a smartphone app called Five Lives MED can improve overall thinking and memory in people with mild cognitive impairment (MCI). Participants use the app three times a week at home for 12 weeks. A comparison group gets a health information leaflet. It is not a drug study, and the phase is not applicable, meaning it is not a standard drug trial.
You may qualify if
- Diagnosis of Mild Cognitive Impairment (also known as mild cognitive disorder [ICD-10-CM; G31.84] or mild neurocognitive disorder (DSM-5)
- Age ≥ 50
- Participant or informant is willing and able to give informed consent for participation in the study
- Ability to read and understand English (UK) or French (France)
- Access to a mobile phone (Apple iOS 12.4 or above or Android 6.0 (Marshmallow) or above) or iPad (Apple iOS 12.4 or above only) with internet connection (mobile or WiFi).
You're excluded if
- Diagnosis of dementia or evidence of functional impairment inconsistent with MCI
- Severe visual impairment
- Currently undergoing any other cognitive remediation programme
- Currently taking part in any other investigational study that in the opinion of the investigator may impact the data integrity of the current study
- Physical impairment that makes using a mobile device impossible
- Lack of access to an informant
- Participant under guardianship
- Unwilling or unable to tolerate or engage with study procedures
- Physical impairment that makes standing/walking unassisted impossible.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-04-29